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In 2012, 14.1 million patients were diagnosed with cancer worldwide of which 385,700 estimated new 
cases of non-Hodgkin lymphoma (NHL). Also, 81,080 new cases of lymphoma were reported in the United 
States (US) among both genders in 2016. In Lebanon, Lymphoma represents the fifth most frequent 
cancer, nonetheless, little is known regarding its epidemiological attributes. This study aims to determine 
the current knowledge of the Lebanese people living in Lebanon about Lymphoma. About 400 
participants were approached in public places, universities, hospitals or work places in different regions 
across Lebanon. A survey including questions about lymph nodes, cancer and lymphoma as well as 
demographic characteristics was given to all eligible participants. The data was collected and analyzed 
using SPSS and p value < 0.05 was considered significant. When asked about the types of cancers they 
knew, the majority of participants (93.5%) were able to identify breast cancer, while less than half of 
(30.67%) identified lymphoma as a cancer. Enlargement of the lymph nodes (LN) was the most common 
recognized symptom (93.4%) whereas 76.42% thought that family history of lymphoma was the most 
frequent risk factor for lymphoma. Among those who claim to know about lymphoma (30%), true in-depth 
knowledge about lymphoma was still lacking. The results of this independently conducted survey reveal 
the lack of awareness about lymphomas among the Lebanese population and highlight the need for 
campaigns to increase the knowledge and awareness. 
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ABSTRACT: In 2012, 14.1 million patients were diagnosed with cancer worldwide of which 
385,700 estimated new cases of non-Hodgkin lymphoma (NHL). Also, 81,080 new cases of 
lymphoma were reported in the United States (US) among both genders in 2016. In Lebanon, 
Lymphoma represents the fifth most frequent cancer, nonetheless, little is known regarding its 
epidemiological attributes. This study aims to determine the current knowledge of the Lebanese 
people living in Lebanon about Lymphoma. About 400 participants were approached in public 
places, universities, hospitals or work places in different regions across Lebanon. A survey 
including questions about lymph nodes, cancer and lymphoma as well as demographic 
characteristics was given to all eligible participants. The data was collected and analyzed using 
SPSS and p value < 0.05 was considered significant. When asked about the types of cancers they 
knew, the majority of participants (93.5%) were able to identify breast cancer, while less than half 
of (30.67%) identified lymphoma as a cancer. Enlargement of the lymph nodes (LN) was the most 
common recognized symptom (93.4%) whereas 76.42% thought that  family history of lymphoma 
was the most frequent risk factor for lymphoma. Among those who claim to know about lymphoma 
(30%), true in-depth knowledge about lymphoma was still lacking. The results of this independently 
conducted survey reveal the lack of awareness about lymphomas among the Lebanese population 
and highlight the need for campaigns to increase the knowledge and awareness.  
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1. INTRODUCTION 
Despite all the progress in the diagnostic and therapeutic arsenal against cancer, lymphoma is still considered a 
worldwide life threatening disease as reported by the European Lymphoma Institute (The European Lymphoma 
Institute, 2017). 
Lymphoma is a type of cancer that affects different cells within the immune system, and is classified as either 
Hodgkin [HL] or non-Hodgkin [NH] lymphoma (Chan, Alexandre, &Gary, 2014). The latter, however, is much 
more common than Hodgkin lymphoma accounting for about 90% of all lymphomas (Shankland, Armitage, & 
Hank, 2012). 
According to World Cancer Research Fund International in 2012, lymphoma was considered to be the 8th most 
common cancer worldwide among males and the 10th most common cancer among females, yet in 2017, as stated 
by the American Cancer Society, it was found to be the seventh-most common cancer among both males and 
females (American Cancer Society, 2017).  In fact, lymphoma`s incidence is globally increasing in such a way 
that every 90 seconds someone is diagnosed with NHL (Roche Survey, 2017). 
As for Lebanon, about 600-700 cases of Hodgkin and NHL are diagnosed yearly (Sader-Ghora et al, 2014). 
Despite this fact, NHL was not considered among the most-reported cancers in Lebanon, until 2008 when it 
recorded 14.1 and 11.6 per 100000 incidence rates among males and females respectively, with expectations of 
increasing incidence rates (Shamseddine et al, 2014). A retrospective study of lymphoma cases diagnosed from 
2008 till 2012 at Hotel-Dieu de France University Hospital was conducted to assess the  distribution of lymphoma.  
The results concluded that the Lebanese patients had unique features and characteristics when compared to other 
countries where Hodgkin Lymphoma was more frequent than other European and American countries (Sader-
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Ghorra et al, 2014). Ebstein Bar Virus (EBV) infection along with other etiologies may explain the higher 
prevalence of HL and NHL among Eastern countries as suggested by a study conducted in Lebabon between 2010 
and 2014 (Aftimos et al, 2018). 
Although many researchers have attempted to spread knowledge and awareness among general population about 
cancer and particularly breast cancer (Fink, 1989), little is done for lymphoma among the population and general 
practitioners as revealed by the conducted Roche survey (2017). In fact, the probability of misdiagnosing 
lymphoma has increased. The lack of awareness on signs and symptoms of lymphoma has driven diagnosis to 
become challenging (Lymphoma Coalition, 2012). “Increasing the level of education and awareness of lymphoma 
is crucial implying that the delay in diagnosis is down to poor general public knowledge concerning lymphomas 
and would influence the effectiveness of treatment”  as quoted by Dr. Sehn (Lymphoma Coalition, 2012). 
The aim of this study is to investigate the extent of knowledge and awareness about lymphoma among the 
general population in Lebanon. 
 
 
2. METHODS AND MATERIALS 
A cross-sectional questionnaire based study was conducted among the Lebanese population to assess the level 
of awareness about lymphoma. Institutional Review Board (IRB) approval was acquired from Beirut Arab 
University (2017H-0060-M-R-0228). A simple random sampling technique was applied to distribute the 
questionnaire to about 400 eligible participants. Any Lebanese person that was 18 years old or above was 
considered eligible to participate in the study. The participants were approached randomly in healthcare clinics, 
universities, places of work and public places. After being informed about the purpose of the research, each 
participant signed an informed consent; the latter assured the confidentiality and anonymity of the personal data.  
Thus, a 10 minute-questionnaire including 20 questions was administered to participants. The questionnaire is 
divided into 2 parts; the first related to participant’s demographic characteristics (age, gender, educational level, 
occupation, family history of cancer and smoking status). The other part included questions to assess the level of 
knowledge of participants on lymphatic system (general knowledge), cancer (causes, risk factors, types and 
screening test), and lymphoma specifically.  
To assess the level of knowledge about lymphoma (11 questions), one point was given to correct answers and 
zero to wrong answers. Total scores thus ranged from 1 to 11. Thus, lymphoma knowledge scores were categorized 
as “not at all aware” (1-2points), “slightly aware” (3-4 points), “somewhat aware” (5-6), “moderately aware” (7-
8), and “extremely aware” (9 and above). 
The questionnaire was made by research team by referring to “Know Your Nodes” survey conducted by 
Lymphoma Canada, Cancer Awareness Measure (CAM) survey and Lymphoma European Roche survey. 
Thereafter, it was reviewed by a pathologist and hematologist for accuracy and validity. It was then pre-tested 
twice for validation.   
The first pilot study was conducted on 11 participants in order to value the feasibility and test the adequacy of 
the survey; also to test the length of the interview and familiarize the investigators in the process of data collection. 
The comments were related to the order, wording and ambiguity of some questions. 
The final version was written in English and then translated to the native language Arabic. The second pilot 
study was conducted on 22 participants after modifying the questionnaire. The feedback remarks were considered 
and adjusted. The developments turned up to be fulfilling the purpose of research. 
 
 
3. RESULTS 
3.1. Socio-Demographic Characteristics 
A total of 401 complete surveys were recruited. 61.8% of the participants were females and 38.2% were males; 
the highest age frequency was between 18 and 27 (65.3%) with a mean age of the sample is 29.33 years 
(SD=13.051). Moreover, the level of education among the participants was as follows: almost half of the 
participants were undergraduates (47.9%), one third of them were post-graduate (33.7 %), about 10% were school 
educated (10.7%), 6.2% were in technical institutes, and lastly 1.5% were non-educated. Likewise, 44% of 
participants were employed with majority working in non-medical fields. 38.4% were smokers and 61.6% were 
non-smokers. Finally, concerning family history of cancer only 37.2% had positive family history of cancer (Table 
1). 
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Table 1: Demographical features of the participants 
Reference: Authors and statistician 
 
3.2. Lymph Node Knowledge 
The knowledge of the participants about their immune system in association with their level of education and 
occupation was analyzed using Pearson chi square test. The results showed that the answer to the definition of 
lymph nodes is significantly related to the participants’ occupation (P=0.006) while no association was related to 
their level of education was observed (P=0.095). Participants working in the medical field had higher accurate 
response to lymph nodes being part of the immune system (75.9% (22 correct answers from 29)).  
When asking about the most common site of lymph nodes in the body, the “neck” was mostly answered by both 
medical and non-medical related occupation participants (51.7% and 43.2% respectively), followed by “armpit” 
(44.8% and 24.3 % respectively), and lastly “anywhere” in the body (31% and 25%).  
As for the question related to the cause of enlarged lymph nodes, significant number of the participants working 
in the medical field answered “infection” (72.4%) compared to the participant in the non-medical field (39.9%) 
(P=0.006).  
Similarly, with respect to the level of education, undergraduate participants mainly answered “infection” to be 
the cause (57.3%) (P=0.021), followed by postgraduates (40.7%), technical (44%), school-level (32.6%) and non-
educated (33.3%).  
As for the cause of lymph node enlargement, no significant relation could be established between the occupation 
and level of education and knowing the cause of lymph node enlargement whether acutely or more than one week 
(Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total participants (N=401)  Percentage (%) 
Gender(n) %   
a) Male (n= 153) 
b) Female (n=248) 
 
 
38.2% 
61.8% 
Age   
a) 18-27 (n=262) 
b) 28-37 (n=45) 
c) 38-47 (n=43) 
d) 48-57 (n=30) 
e) >58 (n=21) 
 
 
 
 
 
65.3% 
11.2% 
10.7% 
7.5% 
5.2% 
Education   
a) Non-educated (n=6) 
b) School (n=43) 
c) Undergraduate (n=192) 
d) Postgraduate (n=135) 
e) Institutional (n=25) 
 
 
 
 
 
1.4% 
10.7% 
47.8% 
33.6% 
6.2% 
Occupation   
a) Medical (n=29) 
b) Non-medical (n=148) 
c) None (n=224) 
 
 
 
7.2% 
36.9% 
55.8% 
Family history of cancer   
a) YES (n=149) 
b)  NO (n=252) 
      37.2%  
      62.8% 
Smoking status  
a) YES (n=154) 
b) NO (n=247) 
      38.4% 
      61.6% 
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Table 2: Frequencies and percentages of participants’ knowledge about lymphatic system in association with level of 
education and occupation 
Reference: Authors and statistician 
   
 
OCCUPATION (N=401) 
 
 
LEVEL OF EDUCATION (N=401) 
 Medical 
(n=29)  
Non-
medic
al 
(n=14
8) 
None 
(n=224) 
Non-
educat
ed 
(n=6) 
Schoo
l 
(n=43) 
Undergradua
te 
(n=192) 
Postgraduat
e 
(n=135) 
Technical 
(n=45) 
 
What do you 
think lymph 
nodes are? 
 
 Glands of the immune 
system 
 
 
Count 
% within 
occupation & 
level of 
education 
 
22  
 
(75.9%) 
 
77 
 
(52%) 
 
150 
 
(67%) 
 
2 
 
(33.3
%) 
 
19 
 
(44.2
%) 
 
133 
 
(69.3%) 
 
80 
 
(59.3%) 
 
15 
 
(60%) 
  
P=0.006 
 
P=0.095 
 
Where can 
you find 
lymph nodes 
in your 
body? 
 
 Armpit 
 
 
Count 
% within 
occupation & 
level of 
education  
 
13 
(44.8%) 
 
36 
(24.3
%) 
 
66 
(29.5%) 
 
3 
(50%) 
 
12 
(57.9
%) 
 
53 
(27.6%) 
 
37 
(27.4%) 
 
10 
(40%) 
  
P=0.058 
 
P=0.312 
 
 neck 
 
Count 
% within 
occupation & 
level of 
education 
 
15 
 
(51.7%) 
 
64 
 
(43.2
%) 
 
88 
 
(39.3%) 
 
1 
 
(16.7
%) 
 
14 
 
(32.6
%) 
 
81 
 
(42.2%) 
 
60 
 
(44.4%) 
 
11 
 
(44%) 
  
P= 0.048 
 
P=0.592 
 
 anywhere 
 
Count 
% within 
occupation & 
level of 
education 
 
9 
 
(31%) 
 
37 
(25%) 
 
78 
(34.8%) 
 
1 
(16.7
%) 
 
10 
(23.3
%) 
 
66 
(34.4%) 
 
42 
(31.1%) 
 
5 
(20%) 
  
P=0.12 
 
P=0.53 
 
Causes of 
enlarged 
lymph nodes 
acutely 
 
 infection 
 
 
Count 
% within 
occupation & 
level of 
education 
 
21 
 
(72.4%) 
 
59 
 
 
112 
 
(50%) 
 
2 
 
 
14 
 
 
110 
 
(57.3%) 
 
55 
 
(40.7%) 
 
11 
 
(44%) 
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(39.9
%) 
(33.3
%) 
(32.6
%) 
  
P=0.006 
 
P=0.021 
 
 cancer 
 
 
Count 
% within 
occupation & 
level of 
education 
 
14 
(48.3%) 
 
34 
(23%) 
 
91 
(40.6%) 
 
1 
(16.7
%) 
 
12 
(27.9
%) 
 
78 
(40.6%) 
 
42 
(31.1%) 
 
6 
(24%) 
  
P=0.003 
 
P=0.192 
 
 immune system 
disorder 
 
Count 
% within 
occupation & 
level of 
education 
  
12 
(41.4%) 
 
51 
(34.5
%) 
 
107 
(47.8%) 
 
0 
(0%) 
 
15 
(34.9
%) 
 
92 
(47.9%) 
 
55 
(40.7%) 
 
8 
(32%) 
  
P=0.083 
 
P=0.148 
 
Causes of 
enlarged 
lymph nodes 
for more than 
1 week 
 
 infection 
 
 
Count 
% within 
occupation & 
level of 
education 
 
12 
(41.4%) 
 
34 
(23%) 
 
63 
(28.1%) 
 
1 
(16.7
%) 
 
7 
(16.3
%) 
 
65 
(33.9%) 
 
32 
(23.7%) 
 
4 
(16%) 
  
P=0.114 
 
P=0.109 
 
 cancer 
 
 
Count 
% within 
occupation & 
level of 
education 
 
12 
(41.4%) 
 
51 
(34.7
%) 
 
105 
(46.9%) 
 
1 
(16.7
%) 
 
13 
(30.2
%) 
 
91 
(47.4%) 
 
52 
(38.8%) 
 
11 
(44%) 
  
P=0.104 
 
P=0.321 
 
 immune system 
disorder 
 
Count 
% within 
occupation & 
level of 
education 
 
14 
(48.%) 
 
51 
(34.7
%) 
 
82 
(36.6%) 
 
1 
(16.7
%) 
 
12 
(27.9
%) 
 
67 
(34.9%) 
 
57 
(42.5%) 
 
10 
(40%) 
  
P=0.147 
 
P=0.493 
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3.3. Cancer Knowledge 
Studying the participants’ familiarity to definition of cancer, there was a significant association with age 
(P=0.005). In other words, younger age group participants [18-27 yr.] were more familiar with cancer definition 
and concept (52.37% (N= 210)). Moreover, participants’ level of education was a significant variable (P=.000) in 
which undergraduates were the most familiar (38.4% (N=154) with definition of cancer followed by post graduates 
(25.93% (N=104)), and occupation medical and non- medical (P=0.013). Table 3. 
Table 3: Percentages of participant familiarity of cancer definition with respect to demographical 
features 
Reference: Authors and statistician 
 
 
 
 
Percentages of participant familiarity of cancer definition n=401 Chi square test  
Age (n=299) 
(74.56%) 
 
Count 
(%)  
[18-27] 
210 
(52.37%) 
 
[28-37] 
31 
(7.73%) 
[38-47] 
30 
(7.48%) 
[48-58] 
17 
(4.23%) 
>58 
11 
(2.74%) 
 
P= 0.005 
     
 
Place of living 
(74.56%) 
 
Count 
(%) 
Beirut 
51 
(12.72%) 
Beqaa 
74 
(18.45%) 
Mount Lebanon 
52 
(12.96%) 
South 
57 
(14.21%) 
North 
65 
(16.21%) 
 
P=0.000 
 
Level of 
education 
(74.56%) 
 
Count 
(%) 
Uneducated 
2 
(0.5%) 
School 
20 
(4.98%) 
Undergraduate 
154 
(38.4%) 
Postgraduate 
104 
(25.93%) 
Technical 
19 
(4.73%) 
 
P=0.000 
 
Occupation 
(74.56%) 
 
Count 
(%) 
Medical 
26 
(6.48%) 
Non-medical 
98 
(24.43%) 
None 
175 
(43.64%) 
 
P=0.013 
 
smoker 
(74.56%) 
 
Count 
(%) 
Yes 
115 
(28.67%) 
No 
184 
(45.88%) 
 
P=0.197 
 
Family history 
of cancer  
(74.56%) 
 
 
 
Count  
(%) 
Yes 
 
118 
(29.42%) 
No 
 
181 
(45.13%) 
 
P=0.093 
 
Gender 
74.56% 
 
Count 
(%) 
Male 
114 
(28.43%) 
Female 
185 
(46.13%) 
 
P=0.996 
 
 
The findings revealed that most of the participants had variable responses regarding the general signs and 
symptoms of cancer, as the data that was collected concerning these aspects was asked in the following binary 
question format (Yes/NO): “Do you think all types of cancer have warning signs and symptoms?” 27.4% of the 
participants said “YES” and 72.6% responded “NO”. The participants thought that the following could be common 
signs or symptoms of cancer: unintentional weight loss (71% (N=286), loss of appetite (61.8% (N=248)), night 
sweats and easy fatigability (51.1% (N=205)). A significant association between the participants’ demographical 
features and their familiarity to cancer signs and symptoms was found, meaning that participants with family 
history of cancer were more familiar to loss of appetite, night sweats and easy fatigability (P=0.003, P= 0.001) 
respectively. In addition, participants working in the medical field were more familiar to the mentioned signs and 
symptoms compared to the non-medical field participants (P=0.043, P=0.008). The other demographical features 
such as gender, age, place of living, level of education and smoking status didn’t show any significant association 
with the familiarity of cancer general signs and symptoms (p>0.05)  (Table 4). 
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Table 4: Association of signs and symptoms of cancer with relative demographical features 
Reference: Authors and statistician 
 
Symptoms of 
cancer 
Age  Gender  Place of 
living 
 
 
Level of 
education 
Occupation Smoker  Family 
history of 
cancer 
Weight loss p=0.749  p=0.896  p=0.575  p=0.625 p=0.081 p=0.79  p=0.194 
Loss of 
appetite 
p= 0.504  p=0.108  p=0.110  p=0.910 p=0.043 p=0.951  p=0.003 
Night sweats 
and easy 
fatigability 
p=0.369  p=0.605  p=0.000  p=0.87 p=0.008 p=0.46  p=0.001 
 
Upon asking the participants about the most heard or known type of cancer, the majority of the participants 
answered breast cancer (93.5% (N=375)), followed by lung cancer (86% (N=345)), colon cancer (65.3% (N=262)), 
prostate (70.8% (N=284)) and eventually lymphoma which was the least known among them (30.7% (N=123))  
As for the most known or commonly heard screening test, mammography was mainly chosen (80.3% (N=322)), 
followed by blood test (73.3% (N=73.3), colonoscopy (50.6% (N=203)), and lastly Pap smear (45.9% (N=184)). 
 
3.4. Sources of Information on Lymphoma 
Participants were asked to choose, among a range of listed sources including school/university, work, doctor, 
organization campaigns, family and friends, internet and others, the source that was behind their information on 
lymphoma. About 70% of participants claimed that school/university was their main source of information about 
lymphoma while the organization campaigns was the least chosen one mentioned by less than 1% (0.8%) of the 
participants. Other sources selected by the respondents were family and friends 13.8%, internet 11.4% and from 
doctors 3.3%. 
 
3.5. Lymphoma Knowledge 
Regarding the first question “Where in the body does lymphoma affect?” the majority (91.86%) agreed that 
lymph nodes will be affected. On the other hand, less than half of the respondents thought that blood (32.52%) and 
bone marrow (17.88%) will also be affected. 
However, as revealed by Pearson’s chi-squared test there was no significant association between knowing that 
lymphoma affects lymph nodes mainly and any of these socio-demographic characteristics level of education, 
occupation and having history of cancer (p>0.05) (Table 5)  
 
Table 5:  Frequencies of participants’ knowledge about lymphoma regarding where it affects, its early detection, and 
screening test in relation with occupation, level of education, and family history of cancer 
Reference: Authors and Statistician 
 Occupation (N’=123) Level of education (N’=123) Family history of 
cancer(N’=123) 
Medic
al 
(n’=1
8) 
Non-
medical 
(n’=28) 
None 
(n’=77
) 
Non-
educate
d 
(n’=1) 
Scho
ol 
(n’=4
) 
Undergradua
te 
(n’=73) 
Postgraduat
e 
(n’=37) 
Techni
cal 
(n’=8) 
Yes 
n’=66
)) 
No 
n’=57)) 
Where do you 
think lymphoma 
affects? 
 blood 
 
9 10 21 1 2 16 18 
 
3 24 16 
 
 
P=0.061 
 
P=0.247 
 
P=0.332 
 Lymph 
nodes 
15 28 70 1 4 67 33 38 62 51 
P= 0.724 P= 0.763 P= 0.370 
 Bone 
marrow  
2 9 11 1 2 11 8 0 13 9 
P= 0.623 P= 0.398 P= 0.577 
Do you think early 
detection of 
lymphoma 
 yes 
 
 
16 
 
26 
 
68 
 
0 
 
2 
 
66 
 
35 
 
7 
 
58 
 
52 
7
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When asked “What tests do you know for diagnosing lymphoma?” the majority (79.9%) were aware that biopsy 
is the used diagnostic tool while the minority thought that mammography (3.3%) , colonoscopy (0.8%) and fecal 
occult blood test (0.8%) can be used for diagnosis. Moreover, few participants (15.4%) were not aware of any of 
the mentioned tests (Table 5). 
As for the (Yes/No) binary question “Do you think that early detection of lymphoma can increase the chance of 
survival?” most of the participants 89.43% (n=110, N’=123) were able to recognize that early detection increases 
the survival; while only 10.56% (n=13, N’=123) thought that it wouldn’t affect survival. 
Similarly for the question “Do you think that lymphoma has a screening test” only 23.57% were aware and 
responded by “No” while the remaining 76.42% responded by “Yes”. (Table 5). 
Furthermore, the answers to the previous two questions were independent of the aware respondents’ socio-
demographics characteristics related to level of education, occupation and having history of cancer (p>0.05) (Table 
5).   
To clarify, when categorizing lymphoma knowledge into extremely aware, moderately aware, somewhat aware, 
slightly aware and not at all aware , the majority of the respondents were considered to be somewhat aware 
(37.34%) and moderately aware (34.14%) based on their score value that ranged from (5-6) and (7-8) respectively, 
fewer were considered to be extremely aware (21.12%) , less than 10% were slightly aware (6.4%) and very small 
portion were not at all aware (0.8%).  
 
 3.6. Risk Factors for Lymphoma  
Respondents were asked to choose among a list of risk factors as many choices as they believed were relevant. 
Family history of lymphoma was the most frequently cited risk factor (76.42%), while the least recognized factors 
were HIV/chronic disease (56.91%) and having previous cancer (55.28%). However, virus (EBV) was poorly 
recognized as a risk factor (37.39%). 
Moreover, there were no any significant relation between the respondents’ answers and any of level of education 
and family history of cancer (p>0.05) (Table 6). 
 
Table 6: Frequencies of participants’ knowledge of lymphoma regarding its signs, symptoms, and risk factors in 
relation to family history of cancer and level of education 
Reference: Authors and statistician 
 
 
Family history of cancer (n’=123) Level of education (n’=123) 
yes 
(n’=66) 
no 
(n’=57) 
non-educated( 
n’=1) 
school 
(n’=4) 
undergraduate 
(n’=51) 
postgraduate 
(n’=31) 
technical 
(n’=8) 
Signs and 
symptoms 
of 
lymphoma 
Enlarged 
lymph 
nodes 
count 63  52
  
1 4 68 34 8 
p= 0.347 P= 0.741 
fever count 42 32 1 3 37 26 7 
p= 0.401 p= 0.039 
night sweats  35 20 1 1 29 19 5 
p= 0.046 p= 0.401 
Risk factors 
of 
lymphoma 
HIV/chronic 
disease 
count 42 
 
28 
 
 
0 2 45 19 4 
p= 0.163 p= 0.668 
having 
previous 
cancer 
count  
41 
27 1 2 42 19 4 
p= 0.102 p= 0.965 
predisposing 
family 
history of 
lymphoma 
count 51 43 0 4 51 31 8 
p= 0.813 p= 0.046 
EBV count 32 14 0 1 31 11 3 
p= 0.006 p= 0.602 
increases risk of 
survival?  
P=0.678 P=0.236 P=0.838 
Do you think 
lymphoma has a 
screening test? 
 yes 
 
15 20 59 1 3 56 28 6 52 42 
P=0.632 P=0.901 P=0.668 
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3.7. Signs and Symptoms of Lymphoma 
 The most widely known symptom of lymphoma was enlarged lymph nodes (93.4%) followed by fever (60.1%) 
and night sweats (44.7%) respectively. 
Based on Pearson’s chi-squared test there were significant association between the level of education and having 
family history of cancer and recognizing the signs and symptoms. Among the respondents undergraduate were 
more likely to recognize fever with significant p value (p=0.039) while those who had family history of cancer 
recognized night sweats (p=0.046) as a symptom (Table 6). 
 
4. DISCUSSION  
As early as the 1950s, numerous campaigns and researches were done to raise awareness towards cancer. 
However, current studies suggest lack of public recognition to early signs of cancer. The lack of apprehension 
towards the gravity of the symptoms remains the predominant risk factor facing society according to two 
systematic literature reviews. Moreover, they have shown that delayed presentation is common when the 
symptoms are of atypical nature (Robb et al, 2009). As an illustration, a study performed on the Iranian general 
population indicated decreased knowledge concerning certain signs and symptoms (Feizi et al, 2011). 
A very high number of our respondents know that lymph nodes are part of the immune system. However, 
regarding the position of the lymph nodes, little knew that lymph nodes are present anywhere in the body (30.9% 
(N=124)). Similarly, most participant answered “infection” as  the cause of acute enlargement of lymph nodes, 
regardless of their level of education and occupation, this result is assured by lymphoma Coalition that built up 
“Know Your Nodes” campaign as a believe that people know little about their lymphatic system (Lymphoma 
Coalition, 2012). 
In reviewing the literature, there was no scale found to measure the general awareness of cancer. In this 
population-based sample, recall of cancer definition as an abnormal growth of cells was identified by 74.6% of the 
participants, by which their answers were influenced by the level of education and age. These results were 
compatible with previous studies that showed the knowledge of cancer in general among the general population 
(Al Wutayd et al, 2015). 
Regarding the three basic symptoms that are involved in all types of cancers (weight loss, loss of appetite, and 
night sweats), the majority of participants (61%) has identified these symptoms in relation to cancer. In addition, 
there was a significant association between their knowledge and the participant’s family history of cancer and 
being in the medical field. It is believed that the cancer campaigns made so far may have an impact on the 
awareness about cancer and its symptoms in Lebanon. However, these results did not match up with a research 
about public awareness of warning signs of cancer in Oman that showed that majority of their participants were 
unaware of common signs and symptoms identified by CAM (Al-Azari et al, 2015). In addition, a similar study 
conducted in the United Kingdom, has shown there is little to no awareness about cancer in general Robb et al, 
2009). 
As for the most common types of cancers known or heard by the participants, Breast cancer showed the highest 
response, followed by lung cancer, colon and skin cancer. Breast cancer continued to be the most reported cancer 
among females, which can be correlated to the high response for “breast cancer” among the participants, and this 
may be due to the influence of the widespread national breast cancer awareness campaigns since 2000 
(Shamseddine et al, 2014). This also can be correlated with the most known screening test by the participants, 
where mammography showed the highest response. Eventually, awareness campaigns that have increased the 
number of women seeking physicians for screening and diagnosis, as well as the wide utilization of mammography 
by NGOs and primary health care centers with the cheapest prices made it easier for women to adopt screening 
programs (Shamseddine et al, 2014). 
The results underline the lack of awareness, where the percentage of participants who knew about lymphoma 
was only 30.67% (N’=123) and those who did not know was 69.32%. Although 123 respondents considered 
themselves aware, it was found that going in depth their knowledge was relatively poor. 
These findings align with other studies, which also demonstrated poor awareness of lymphoma. In accordance 
to Roche survey that was conducted on the general population in five European countries, awareness of lymphoma 
was low where about a third (32%) of respondents were unable to identify lymphoma as a type of cancer at all 
(Roche Survey, 2017). 
Participants tended to have only a basic knowledge of lymphoma and were unaware of many important factors. 
For example, while having family history of lymphoma was by far the most identified risk factor (76.42%), less 
than half of participants mentioned virus (EBV) as a risk factor. However, in fact, according to Cancer Research 
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UK Hodgkin, lymphoma risk is 2.6-6 times higher in people with a history of infectious mononucleosis associated 
with EBV while only 3 times higher in those with positive family history of lymphoma (Cancer research UK). 
According to Roche survey less than half of the enrolled participants were able to identify signs and symptoms 
of lymphoma (Roche Survey, 2017). Interestingly, the findings of our study showed that out of 123 who claimed 
awareness about lymphoma 44 participants (35.77%) were aware of all the items. On the other hand, 39 
participants (31.70%) selected two out of three of the symptoms and 33 participants (26.82%) selected only one 
symptom with only 7 participants (5.69%), reported that they weren’t familiar with any of the mentioned signs 
and symptoms. Moreover, both patients and general physicians usually overlook these symptoms because they 
mimic symptoms of less serious illnesses such as influenza or other viral infection (Lymphoma Coalition). In 
addition to that, there is misconception among the general population about lymphoma’s screening tests where 
76.42% mistakenly thought that lymphoma can be screened. However, in reality at present time, there is no 
screening test for lymphoma and it is usually not manifested in the blood (Lymphoma Coalition). Accordingly, 
the lack of awareness of these symptoms, delayed detection, and absence of screening tests have contributed to 
increase the probability of lymphoma misdiagnosis and thereby impeding the patient’s chances for early and 
successful treatment. 
 
5. CONCLUSIONS  
This study demonstrated the lack of awareness and knowledge of the Lebanese population regarding the risk 
factors, clinical presentation, diagnosis and treatment of lymphoma. We believe that awareness campaigns and 
courses should be held to raise awareness and knowledge about lymphoma. 
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